我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

辛伐他汀对脂多糖诱导新生大鼠心肌成纤维细胞NO生成和AT2R蛋白表达抑制的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2007年第3期
页码:
252-254
栏目:
基础研究
出版日期:
2007-06-01

文章信息/Info

Title:
Effects of Simvastatin on LPS induced NO production and AT2R expression in rat cardiac fibroblasts
作者:
刘少伟; 赵连友; 郑强荪; 尚福军; 张丽娟; 刘慧; 何燕萍; 赵晓燕
第四军医大学唐都医院心内科，陕西 西安 710038
Author(s):
LIU Shaowei;  ZHAO Lianyou;  Zheng Qiangsun;  SHANG Fujun;  ZHANG Lijuan;  LIU Hui;  HE Yanping;  ZHAO Xiaoyan
Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi′an 710038, Shaanxi, China
关键词:
他汀类药物; 心肌成纤维细胞; 一氧化氮; 血管紧张素Ⅱ受体2型
Keywords:
statins; cardiac fibroblasts; nitric oxide; angiotensin Ⅱ type 2 receptor; apoptosis
分类号:
R542.2；R972.6
DOI:
-
文献标识码:
A
摘要:
目的 研究辛伐他汀（Sim）对脂多糖（LPS）调控心肌成纤维细胞（CFs）一氧化氮（NO）生成和血管紧张素Ⅱ受体2型（AT2R）蛋白表达的干预效应。方法 体外培养新生大鼠CFs，以第1代CFs作为实验对象，采用硝酸还原酶法测定细胞内NO产量，Western blot检测细胞AT2R蛋白的表达，以AT2R/βactin值对AT2R表达进行半定量。结果 与LPS（10 mg/L）单独作用组相比，0.01 μmol/L和0.1 μmol/L Sim与LPS共同作用组CFs的NO生成和AT2R/βactin值无显著差异 ；在1 μmol/L和10 μmol/L Sim与LPS共同作用组，NO生成量显著低于LPS单独作用组（均P<0.01），而AT2R/βactin值显著高于LPS单独作用组（分别有P<0.05和P<0.01）。结论 高浓度Sim可拮抗LPS引起的NO生成增加和AT2R蛋白表达下降。
Abstract:
AIM To investigate the effects of Simvastatin (Sim) on lipopolysaccharides (LPS)induced changes in nitric oxide (NO) production and angiotensin Ⅱ type 2 receptor (AT2R) expression in cardiac fibroblasts (CFs). METHODS First cultures of neonatal rat CFs were employed in the present study. After incubating cells with LPS, the production of intrinsic nitric oxide (NO) was determined using nitrate reductase measurement. The protein levels of AT2R was determined by Western blot analysis. RESULTS No significant difference was observed in NO production and AT2R protein expression (shown as AT2R/βactin) when CFs were incubated with Sim (0.01 μmol/L) plus LPS (10 mg/L) or Sim (0.1 μmol/L) plus LPS (10 mg/L) and incubated with LPS alone. NO production increased significantly when CFs were incubated with 1 μmol/L or 10 μmol/L Sim in the presence of LPS, compared with LPS alone (both P<0.01), while AT2R/βactin decreased significantly in the coincubated groups (P<0.05 and P<0.01, respectively). CONCLUSION High concentrations of Sim antagonize LPS in the induction of NO release and the inhibition of AT2R protein expression.

参考文献/References

［1］田建伟，赵连友，王士雯，等.阿伐他汀对幼年大鼠心肌成纤维细胞增殖和胶原合成的影响及其意义［J］.中华医学杂志, 2003, 83（2）:118-122.

［2］Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphateinduced calcification by restoring Gas6Axl survival pathway［J］. Circ Res, 2006, 98（8）:1024-1031.

［3］Massion PB, Pelat M, Belge C, et al. Regulation of the mammalian heart function by nitric oxide［J］. Comp Biochem Physiol A Mol Integr Physiol, 2005, 142（2）:144-150.

［4］Diez J, Lopez B, Gonzalez A, et al. Clinical aspects of hypertensive myocardial fibrosis［J］. Curr Opin Cardiol, 2001, 16（6）:328-335.

［5］Choi BM, Pae HO, Jang SI, et al. Nitric oxide as a pro-apoptotic as well as anti-apototic modulator［J］. J Biochem Mol Biol, 2002, 35（1）:116-126.

［6］de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology: XXIII. The angiotensin II receptors［J］. Pharmacol Rev, 2000, 52（3）:415-472.

［7］Wharton J, Morgan K, Rutherford RA, et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart［J］. J Pharmacol Exp Ther, 1998, 284（1）:323-336.

［8］Bartunek J, Weinberg EO, Tajima M, et al. Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts［J］. Circulation, 1999, 99（1）:22-25.

［9］Yan X, Price RL, Nakayama M, et al. Ventricularspecific expression of angiotensin II Type 2 receptor causes dilated cardiomyopathy and heart failure in transgenic mice［J］. Am J Physiol Heart Circ Physiol, 2003, 285（5）:H2179-H2187.

［10］Tamura M, Chen YJ, Howard EF, et al. Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts［J］. Eur J Pharmacol, 1999, 386（2-3）:289-295.

备注/Memo

备注/Memo:
收稿日期：2006-08-08.基金项目：陕西省自然科学基金项目资助(No.2004C221)通讯作者：赵连友，主任医师，主要从事高血压发病的分子生物学机制研究Email：zhaolyfmmu@yahoo.com.cn 作者简介：刘少伟，硕士生Email：lswly2000@163.com
更新日期/Last Update: